Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Camille Bouchard

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Clinical Medicine|July 29, 2023
Limb-Girdle Muscular Dystrophies Classification and TherapiesCamille Bouchard, Jacques P Tremblay
Journal of Clinical Medicine|September 28, 2023
Portrait of Dysferlinopathy: Diagnosis and Development of TherapyCamille Bouchard, Jacques P Tremblay
Medecine Sciences : M/S|October 25, 2024
[Correcting pathogenic mutations using prime editing: an overview]Camille Bouchard, Kelly Godbout, Jacques P Tremblay
Genes & Diseases|January 26, 2026
Molecular characterization of a new R1925X point mutation mouse model for dysferlinopathyCamille Bouchard, Louis Despax, Joël Rousseau, et al.
Behavioural Brain Research|September 11, 2022
A promising mouse model for Friedreich Ataxia progressing like human patientsCatherine Gérard, Annabelle Fortin Archambault, Camille Bouchard, et al.
Cells|May 27, 2026
Gene Editing Strategies for Duchenne Muscular Dystrophy: From Molecular Mechanisms to Clinical TranslationAyesha Siddika, Joël Rousseau, Félix Veillette, et al.
International Journal of Molecular Sciences|June 26, 2025
In Vitro Correction of Point Mutations in the <i>DYSF</i> Gene Using Prime EditingCamille Bouchard, Joël Rousseau, Gabriel Lamothe, et al.
Genes|August 26, 2023
Finding an Appropriate Mouse Model to Study the Impact of a Treatment for Friedreich Ataxia on the Behavioral PhenotypeCamille Bouchard, Catherine Gérard, Solange Gni-Fiene Yanyabé, et al.
Australasian Journal on Ageing|November 28, 2023
Factors influencing older adults' participation in telehealth interventions for primary prevention and health promotion: A rapid reviewSamuel Turcotte, Camille Bouchard, Jacqueline Rousseau, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Clinical Medicine|July 29, 2023
Limb-Girdle Muscular Dystrophies Classification and TherapiesCamille Bouchard, Jacques P Tremblay
Journal of Clinical Medicine|September 28, 2023
Portrait of Dysferlinopathy: Diagnosis and Development of TherapyCamille Bouchard, Jacques P Tremblay
Medecine Sciences : M/S|October 25, 2024
[Correcting pathogenic mutations using prime editing: an overview]Camille Bouchard, Kelly Godbout, Jacques P Tremblay
Genes & Diseases|January 26, 2026
Molecular characterization of a new R1925X point mutation mouse model for dysferlinopathyCamille Bouchard, Louis Despax, Joël Rousseau, et al.
Behavioural Brain Research|September 11, 2022
A promising mouse model for Friedreich Ataxia progressing like human patientsCatherine Gérard, Annabelle Fortin Archambault, Camille Bouchard, et al.
Cells|May 27, 2026
Gene Editing Strategies for Duchenne Muscular Dystrophy: From Molecular Mechanisms to Clinical TranslationAyesha Siddika, Joël Rousseau, Félix Veillette, et al.
International Journal of Molecular Sciences|June 26, 2025
In Vitro Correction of Point Mutations in the <i>DYSF</i> Gene Using Prime EditingCamille Bouchard, Joël Rousseau, Gabriel Lamothe, et al.
Genes|August 26, 2023
Finding an Appropriate Mouse Model to Study the Impact of a Treatment for Friedreich Ataxia on the Behavioral PhenotypeCamille Bouchard, Catherine Gérard, Solange Gni-Fiene Yanyabé, et al.
Australasian Journal on Ageing|November 28, 2023
Factors influencing older adults' participation in telehealth interventions for primary prevention and health promotion: A rapid reviewSamuel Turcotte, Camille Bouchard, Jacqueline Rousseau, et al.
Pageof 1